These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 36861722)

  • 1. External validation of the PATHFx decision-support tool on Turkish patients with skeletal metastasis.
    Ozkan K; Ozturan B; Karadag Z; Erol B; Alpan B; Ozger H; Gurkan V; Sofulu O; Yalcinkaya M; Okay E; Forsberg JA
    Indian J Cancer; 2023 Feb; ():. PubMed ID: 36861722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External Validation of PATHFx Version 3.0 in Patients Treated Surgically and Nonsurgically for Symptomatic Skeletal Metastases.
    Anderson AB; Wedin R; Fabbri N; Boland P; Healey J; Forsberg JA
    Clin Orthop Relat Res; 2020 Apr; 478(4):808-818. PubMed ID: 32195761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can A Multivariate Model for Survival Estimation in Skeletal Metastases (PATHFx) Be Externally Validated Using Japanese Patients?
    Ogura K; Gokita T; Shinoda Y; Kawano H; Takagi T; Ae K; Kawai A; Wedin R; Forsberg JA
    Clin Orthop Relat Res; 2017 Sep; 475(9):2263-2270. PubMed ID: 28560532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can We Estimate Short- and Intermediate-term Survival in Patients Undergoing Surgery for Metastatic Bone Disease?
    Forsberg JA; Wedin R; Boland PJ; Healey JH
    Clin Orthop Relat Res; 2017 Apr; 475(4):1252-1261. PubMed ID: 27909972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting survival of patients with spinal metastatic disease using PathFx 3.0 - A validation study of 668 patients in Sweden.
    Carrwik C; Tsagkozis P; Wedin R; Robinson Y
    Brain Spine; 2022; 2():101669. PubMed ID: 36506283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of PATHFx 2.0: An open-source tool for estimating survival in patients undergoing pathologic fracture fixation.
    Overmann AL; Clark DM; Tsagkozis P; Wedin R; Forsberg JA
    J Orthop Res; 2020 Oct; 38(10):2149-2156. PubMed ID: 32492213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do we estimate survival? External validation of a tool for survival estimation in patients with metastatic bone disease-decision analysis and comparison of three international patient populations.
    Piccioli A; Spinelli MS; Forsberg JA; Wedin R; Healey JH; Ippolito V; Daolio PA; Ruggieri P; Maccauro G; Gasbarrini A; Biagini R; Piana R; Fazioli F; Luzzati A; Di Martino A; Nicolosi F; Camnasio F; Rosa MA; Campanacci DA; Denaro V; Capanna R
    BMC Cancer; 2015 May; 15():424. PubMed ID: 25998535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of survival after surgical management of femoral metastatic bone disease - A comparison of prognostic models.
    Meares C; Badran A; Dewar D
    J Bone Oncol; 2019 Apr; 15():100225. PubMed ID: 30847272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External Validation and Optimization of the SPRING Model for Prediction of Survival After Surgical Treatment of Bone Metastases of the Extremities.
    Sørensen MS; Gerds TA; Hindsø K; Petersen MM
    Clin Orthop Relat Res; 2018 Aug; 476(8):1591-1599. PubMed ID: 30020148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can a Bayesian belief network for survival prediction in patients with extremity metastases (PATHFx) be externally validated in an Asian cohort of 356 surgically treated patients?
    Hsieh HC; Lai YH; Lee CC; Yen HK; Tseng TE; Yang JJ; Ling SY; Hu MH; Hou CH; Yang RS; Wedin R; Forsberg JA; Lin WH
    Acta Orthop; 2022 Sep; 93():721-731. PubMed ID: 36083697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine learning algorithms to estimate 10-Year survival in patients with bone metastases due to prostate cancer: toward a disease-specific survival estimation tool.
    Anderson AB; Grazal C; Wedin R; Kuo C; Chen Y; Christensen BR; Cullen J; Forsberg JA
    BMC Cancer; 2022 Apr; 22(1):476. PubMed ID: 35490227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients.
    Qiu PF; Liu JJ; Wang YS; Yang GR; Liu YB; Sun X; Wang CJ; Zhang ZP
    Jpn J Clin Oncol; 2012 Nov; 42(11):1002-7. PubMed ID: 23100610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of Memorial Sloan-Kettering Cancer Center nomogram for prediction of non-sentinel lymph node metastasis in sentinel lymph node positive breast cancer patients an international comparison.
    Kuo YL; Chen WC; Yao WJ; Cheng L; Hsu HP; Lai HW; Kuo SJ; Chen DR; Chang TW
    Int J Surg; 2013; 11(7):538-43. PubMed ID: 23707626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the likelihood of additional lymph node metastasis in sentinel lymph node positive breast cancer: validation of the Memorial Sloan-Kettering Cancer Centre (MSKCC) nomogram.
    Chue KM; Yong WS; Thike AA; Ahmed SS; Li HH; Wong CY; Ho GH; Madhukumar P; Tan BK; Ong KW; Tan PH
    J Clin Pathol; 2014 Feb; 67(2):112-9. PubMed ID: 24048026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between different prognostic models to be used for metastatic bone disease on appendicular skeleton in a Chilean population.
    Alfaro PA; Delgado J; Dumas A; Mesa C; Wevar O; Herrera C; Padilla F; Botello E
    Eur J Orthop Surg Traumatol; 2021 Dec; 31(8):1657-1662. PubMed ID: 34677661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk factors of non-sentinel lymph node metastasis and performance of MSKCC nomogramin breast cancer patients with metastatic sentinel lymph node].
    Huang J; Chen X; Fei X; Huang O; Wu J; Zong Y; Zhu L; He J; Chen W; Li Y; Shen K
    Zhonghua Wai Ke Za Zhi; 2015 Dec; 53(12):941-6. PubMed ID: 26850667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of sorafenib correlates with Memorial Sloan-Kettering Cancer Center (MSKCC) risk classification and bone metastasis in Chinese patients with metastatic renal cell carcinoma.
    Zhang Y; Li Y; Cai Y; Wang K; Li H
    Cell Oncol (Dordr); 2016 Feb; 39(1):15-21. PubMed ID: 26597814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative ultrasound-based radiomics score can improve the accuracy of the Memorial Sloan Kettering Cancer Center nomogram for predicting sentinel lymph node metastasis in breast cancer.
    Zha HL; Zong M; Liu XP; Pan JZ; Wang H; Gong HY; Xia TS; Liu XA; Li CY
    Eur J Radiol; 2021 Feb; 135():109512. PubMed ID: 33429302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of an existing and modified model for predicting non sentinel lymph node metastasis in breast cancer patients with positive sentinel node biopsy.
    Al-Masri M; Darwazeh G; El-Ghanem M; Hamdan B; Sughayer M
    Gulf J Oncolog; 2013 Jan; 1(13):15-22. PubMed ID: 23339977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of Memorial Sloan Kettering Cancer Center nomogram and prediction of optimal candidate for lymph node dissection in clinically localized prostate cancer.
    Milonas D; Venclovas Z; Muilwijk T; Jievaltas M; Joniau S
    Cent European J Urol; 2020; 73(1):19-25. PubMed ID: 32395318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.